300765SZSE

2025 Annual Report of Independent Director (Yang Peng)

✨ AI Summary

This report details Independent Director Yang Peng's performance in 2025. He attended all board and shareholder meetings, reviewed proposals, and issued independent opinions on various matters including financial reports, appointments, and related-party transactions, ensuring compliance and protecting shareholder interests.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stone Pharmaceutical Pharmaceutical Co., Ltd. 2025 Annual Report of Independent Director

To all shareholders and shareholder representatives:

As an independent director of Stone Pharmaceutical Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), during my tenure, I have strictly adhered to the Company Law, Securities Law, and other laws and regulations, as well as the Articles of Association and the Independent Director Work Rules. I have diligently exercised my rights and fulfilled my duties, ensuring that I am not influenced or swayed by the Company's major shareholders, actual controllers, or other parties with vested interests. I have fully played the role of an independent director, supervised the Company's standardized operations, and protected the overall interests of shareholders. The following is a report on the basic situation of my duties in 2025:

I. Basic Information of Independent Director

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.